Literature DB >> 31456036

Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressants.

Kenji Hashimoto1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31456036     DOI: 10.1007/s00406-019-01061-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  10 in total

1.  Combined cognitive, psychomotor and electrophysiological biomarkers in major depressive disorder.

Authors:  Ping Chai Koo; Christoph Berger; Golo Kronenberg; Julia Bartz; Peter Wybitul; Olaf Reis; Jacqueline Hoeppner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-11-03       Impact factor: 5.270

2.  Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Authors:  Stephanie Debette; Sophie Visvikis-Siest; Ming-Huen Chen; Ndeye-Coumba Ndiaye; Ci Song; Anita Destefano; Radwan Safa; Mohsen Azimi Nezhad; Douglas Sawyer; Jean-Brice Marteau; Vanessa Xanthakis; Gerard Siest; Lisa Sullivan; Michele Pfister; Holly Smith; Seung-Hoan Choi; John Lamont; Lars Lind; Qiong Yang; Peter Fitzgerald; Erik Ingelsson; Ramachandran S Vasan; Sudha Seshadri
Journal:  Circ Res       Date:  2011-07-14       Impact factor: 17.367

3.  Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder.

Authors:  LeHoa Nguyen; Shingo Kakeda; Asuka Katsuki; Koichiro Sugimoto; Yuka Otsuka; Issei Ueda; Ryohei Igata; Keita Watanabe; Taro Kishi; Nakao Iwata; Yukunori Korogi; Reiji Yoshimura
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-11-07       Impact factor: 5.270

Review 4.  Ketamine: A Paradigm Shift for Depression Research and Treatment.

Authors:  John H Krystal; Chadi G Abdallah; Gerard Sanacora; Dennis S Charney; Ronald S Duman
Journal:  Neuron       Date:  2019-03-06       Impact factor: 17.173

5.  Cerebral blood flow responses during prosaccade and antisaccade preparation in major depression.

Authors:  Alexandra Hoffmann; Ulrich Ettinger; Casandra Montoro; Gustavo A Reyes Del Paso; Stefan Duschek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-11-12       Impact factor: 5.270

6.  Increased levels of vascular endothelial growth factor in patients with major depressive disorder: A meta-analysis.

Authors:  Ping-Tao Tseng; Yu-Shian Cheng; Yen-Wen Chen; Ching-Kuan Wu; Pao-Yen Lin
Journal:  Eur Neuropsychopharmacol       Date:  2015-06-20       Impact factor: 4.600

7.  Role of Neuronal VEGF Signaling in the Prefrontal Cortex in the Rapid Antidepressant Effects of Ketamine.

Authors:  Satoshi Deyama; Eunyoung Bang; Eric S Wohleb; Xiao-Yuan Li; Taro Kato; Danielle M Gerhard; Sophie Dutheil; Jason M Dwyer; Seth R Taylor; Marina R Picciotto; Ronald S Duman
Journal:  Am J Psychiatry       Date:  2019-01-04       Impact factor: 18.112

8.  AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.

Authors:  Chun Yang; Shizuka Kobayashi; Kazuhito Nakao; Chao Dong; Mei Han; Youge Qu; Qian Ren; Ji-Chun Zhang; Min Ma; Hidetoh Toki; Jun-Ichi Yamaguchi; Shigeyuki Chaki; Yukihiko Shirayama; Kazu Nakazawa; Toshiya Manabe; Kenji Hashimoto
Journal:  Biol Psychiatry       Date:  2018-05-14       Impact factor: 12.810

Review 9.  Rapid-acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-11       Impact factor: 5.188

10.  Is (S)-norketamine an alternative antidepressant for esketamine?

Authors:  Kenji Hashimoto; Chun Yang
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-14       Impact factor: 5.270

  10 in total
  1 in total

Review 1.  The molecular pathophysiology of depression and the new therapeutics.

Authors:  Haihua Tian; Zhenyu Hu; Jia Xu; Chuang Wang
Journal:  MedComm (2020)       Date:  2022-07-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.